Insider trades › Eric Venker
Eric Venker
A corporate insider: an officer, director or owner of more than 10% of a company. Insiders report their trades to the SEC on Form 4The form insiders use to report each purchase or sale of their company's stock. It is due within two business days of the trade. · Last filing Nov 12, 2026
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, list Eric Venker's open-market buys and sells across companies in the last two years, with the Form 4 links.
Using 13F.ai, how did the stocks Eric Venker bought perform after the purchase compared with the S&P 500?
Using 13F.ai, are other insiders at the same companies buying or selling at the same time as Eric Venker?
Connect your AI · Plans and the 7-day free trial (card required)
Buying and selling by quarter
Dollars bought and sold on the open market over the last two years.
Bought Sold
By trade date, using the shares and price reported for each trade. Stock grants, option exercises and shares withheld for tax are left out.
Roles
The companies where this person reports as an insider, and their position at each, most recent first.
Latest open-market trades
Purchases and sales at every company, most recent filing first.
| How the stock has done since the trade date, measured against the S&P 500 over the same days. It describes the stock, not the trader's actual gain or loss. | Filing | ||||||
|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | ROIV Roivant Sciences Ltd. | Sale | 158,194 | $40.44 | $6.4M | -4.6% | Form 4 ↗ |
| Nov 10, 2026 | ROIV Roivant Sciences Ltd. | Sale | 29,749 | $41.00 | $1.2M | -4.6% | Form 4 ↗ |
| Nov 3, 2026 | ROIV Roivant Sciences Ltd. | Sale | 200,000 | $36.31 | $7.3M | +9.7% | Form 4 ↗ |
| Oct 28, 2026 | ROIV Roivant Sciences Ltd. | Sale | 200,000 | $36.59 | $7.3M | +8.8% | Form 4 ↗ |
| Oct 20, 2026 | ROIV Roivant Sciences Ltd. | Sale | 185,856 | $35.09 | $6.5M | +15.1% | Form 4 ↗ |
| Oct 20, 2026 | ROIV Roivant Sciences Ltd. | Sale | 14,144 | $35.42 | $501.0K | +15.1% | Form 4 ↗ |
| Aug 28, 2026 | ROIV Roivant Sciences Ltd. | Sale | 166,182 | $35.63 | $5.9M | +15.8% | Form 4 ↗ |
| Aug 28, 2026 | ROIV Roivant Sciences Ltd. | Sale | 33,818 | $36.44 | $1.2M | +15.8% | Form 4 ↗ |
| Jul 27, 2026 | ROIV Roivant Sciences Ltd. | Sale | 200,000 | $34.95 | $7.0M | +11.8% | Form 4 ↗ |
| Jul 2, 2026 | IMVT Immunovant, Inc. | Sale | 3,092 | $38.48 | $119.0K | -13.2% | Form 4 ↗ |
| Jun 24, 2026 | ROIV Roivant Sciences Ltd. | Sale | 153,766 | $33.05 | $5.1M | +13.3% | Form 4 ↗ |
| Jun 24, 2026 | ROIV Roivant Sciences Ltd. | Sale | 46,234 | $33.51 | $1.5M | +13.3% | Form 4 ↗ |
| May 22, 2026 | ROIV Roivant Sciences Ltd. | Sale | 200,000 | $30.27 | $6.1M | +30.8% | Form 4 ↗ |
| Apr 20, 2026 | ROIV Roivant Sciences Ltd. | Sale | 200,000 | $29.59 | $5.9M | +29.5% | Form 4 ↗ |
| Apr 2, 2026 | IMVT Immunovant, Inc. | Sale | 12,820 | $24.04 | $308.2K | +24.5% | Form 4 ↗ |
| Apr 2, 2026 | IMVT Immunovant, Inc. | Sale | 1,409 | $24.60 | $34.7K | +24.5% | Form 4 ↗ |
| Mar 17, 2026 | ROIV Roivant Sciences Ltd. | Sale | 200,000 | $28.24 | $5.6M | +27.2% | Form 4 ↗ |
| Feb 13, 2026 | ROIV Roivant Sciences Ltd. | Sale | 200,000 | $26.49 | $5.3M | +38.8% | Form 4 ↗ |
| Jan 12, 2026 | ROIV Roivant Sciences Ltd. | Sale | 200,000 | $21.92 | $4.4M | +69.9% | Form 4 ↗ |
| Dec 24, 2025 | ROIV Roivant Sciences Ltd. | Sale | 75,000 | $22.53 | $1.7M | +66.4% | Form 4 ↗ |
| Dec 23, 2025 | ROIV Roivant Sciences Ltd. | Sale | 200,000 | $22.45 | $4.5M | +66.4% | Form 4 ↗ |
| Dec 9, 2025 | ROIV Roivant Sciences Ltd. | Sale | 200,000 | $20.85 | $4.2M | +83.0% | Form 4 ↗ |
| Nov 7, 2025 | ROIV Roivant Sciences Ltd. | Sale | 200,000 | $20.22 | $4.0M | +79.3% | Form 4 ↗ |
| Oct 17, 2025 | ROIV Roivant Sciences Ltd. | Sale | 118,418 | $17.06 | $2.0M | +115.5% | Form 4 ↗ |
| Oct 16, 2025 | ROIV Roivant Sciences Ltd. | Sale | 318,282 | $17.05 | $5.4M | +116.8% | Form 4 ↗ |
| Oct 15, 2025 | ROIV Roivant Sciences Ltd. | Sale | 414,683 | $16.93 | $7.0M | +119.3% | Form 4 ↗ |
| Oct 13, 2025 | ROIV Roivant Sciences Ltd. | Sale | 20,727 | $16.25 | $336.8K | +130.1% | Form 4 ↗ |
| Oct 9, 2025 | ROIV Roivant Sciences Ltd. | Sale | 104,940 | $16.30 | $1.7M | +132.8% | Form 4 ↗ |
| Oct 8, 2025 | ROIV Roivant Sciences Ltd. | Sale | 138,602 | $16.20 | $2.2M | +134.5% | Form 4 ↗ |
| Oct 7, 2025 | ROIV Roivant Sciences Ltd. | Sale | 355,161 | $16.15 | $5.7M | +132.5% | Form 4 ↗ |
| Oct 6, 2025 | ROIV Roivant Sciences Ltd. | Sale | 171,396 | $16.34 | $2.8M | +130.8% | Form 4 ↗ |
| Sep 23, 2025 | ROIV Roivant Sciences Ltd. | Sale | 611,000 | $14.83 | $9.1M | +154.4% | Form 4 ↗ |
| Sep 22, 2025 | ROIV Roivant Sciences Ltd. | Sale | 316,182 | $14.99 | $4.7M | +151.5% | Form 4 ↗ |
| Sep 22, 2025 | ROIV Roivant Sciences Ltd. | Sale | 100,000 | $15.01 | $1.5M | +151.5% | Form 4 ↗ |
| Sep 19, 2025 | ROIV Roivant Sciences Ltd. | Sale | 683,818 | $14.95 | $10.2M | +149.2% | Form 4 ↗ |
| Aug 20, 2025 | ROIV Roivant Sciences Ltd. | Sale | 100,000 | $11.72 | $1.2M | +219.1% | Form 4 ↗ |
| Jul 21, 2025 | ROIV Roivant Sciences Ltd. | Sale | 100,000 | $11.52 | $1.2M | +224.4% | Form 4 ↗ |
| Jun 20, 2025 | ROIV Roivant Sciences Ltd. | Sale | 100,000 | $11.45 | $1.1M | +218.3% | Form 4 ↗ |
| Jun 3, 2025 | ROIV Roivant Sciences Ltd. | Sale | 566,278 | $11.22 | $6.4M | +225.0% | Form 4 ↗ |
| Jun 2, 2025 | ROIV Roivant Sciences Ltd. | Sale | 433,722 | $11.07 | $4.8M | +226.6% | Form 4 ↗ |
| May 20, 2025 | ROIV Roivant Sciences Ltd. | Sale | 100,000 | $10.95 | $1.1M | +230.8% | Form 4 ↗ |
| Apr 21, 2025 | ROIV Roivant Sciences Ltd. | Sale | 100,000 | $10.22 | $1.0M | +246.9% | Form 4 ↗ |
| Mar 24, 2025 | ROIV Roivant Sciences Ltd. | Sale | 434,478 | $10.82 | $4.7M | +233.6% | Form 4 ↗ |
| Mar 20, 2025 | ROIV Roivant Sciences Ltd. | Sale | 315,522 | $11.06 | $3.5M | +226.9% | Form 4 ↗ |
| Feb 20, 2025 | ROIV Roivant Sciences Ltd. | Sale | 100,000 | $10.65 | $1.1M | +245.2% | Form 4 ↗ |
| Feb 13, 2025 | ROIV Roivant Sciences Ltd. | Sale | 218,041 | $10.42 | $2.3M | +254.6% | Form 4 ↗ |
| Feb 12, 2025 | ROIV Roivant Sciences Ltd. | Sale | 217,384 | $10.53 | $2.3M | +253.6% | Form 4 ↗ |
| Jan 21, 2025 | ROIV Roivant Sciences Ltd. | Sale | 100,000 | $11.28 | $1.1M | +225.7% | Form 4 ↗ |
| Dec 30, 2024 | ROIV Roivant Sciences Ltd. | Sale | 177,704 | $11.54 | $2.1M | +217.6% | Form 4 ↗ |
| Dec 27, 2024 | ROIV Roivant Sciences Ltd. | Sale | 176,900 | $11.82 | $2.1M | +208.2% | Form 4 ↗ |
| Dec 20, 2024 | ROIV Roivant Sciences Ltd. | Sale | 100,000 | $11.49 | $1.1M | +214.0% | Form 4 ↗ |
| Nov 20, 2024 | ROIV Roivant Sciences Ltd. | Sale | 100,000 | $11.32 | $1.1M | +216.3% | Form 4 ↗ |
| Oct 21, 2024 | ROIV Roivant Sciences Ltd. | Sale | 100,000 | $11.65 | $1.2M | +210.9% | Form 4 ↗ |
Each row links to its Form 4. Since trade compares the stock’s move from the close on the trade date (or the next trading day) to its latest close with the S&P 500 over the same days, adjusted for splits and excluding dividends. It describes the stock, not what the trader made: we don’t know their purchase price, position size or later sales. A dash means the trade isn’t matched to a listed stock, or there is no closing price after it yet.
When several people report on the same filing, we list it under the first one named, so trades by someone usually listed second may be missing here. Information, not investment advice: see the disclaimer.